-
1
-
-
27144456549
-
-
Cochrane Metabolic and Endocrine Disorders Group. Oxford: Update Software
-
Richter B, Berger M, Bergerhoff K, Clar C, De Leiva A, Manning P, et al. Cochrane Metabolic and Endocrine Disorders Group. En: Cochrane Library, Issue 3. Oxford: Update Software, 2001.
-
(2001)
Cochrane Library
, Issue.3
-
-
Richter, B.1
Berger, M.2
Bergerhoff, K.3
Clar, C.4
De Leiva, A.5
Manning, P.6
-
3
-
-
84990931057
-
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
-
Oxford: Update Software
-
Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Cochrane Review). En: Cochrane Library, Issue 4. Oxford: Update Software; 2003.
-
(2003)
Cochrane Library
, Issue.4
-
-
Salpeter, S.1
Greyber, E.2
Pasternak, G.3
Salpeter, E.4
-
4
-
-
0029132285
-
Worldwide experience of metformin as an effective glucose-lowering agent: A meta-analysis
-
Campbell TW, Hewlett HCS . Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis. Diabetes Metab Rev. 1995;11 Suppl 1:57-62.
-
(1995)
Diabetes Metab Rev
, vol.11
, Issue.SUPPL. 1
, pp. 57-62
-
-
Campbell, T.W.1
Hewlett, H.C.S.2
-
5
-
-
0032929173
-
Efficacy of metformin in the treatment of NIDDM. Meta-analysis
-
Johansen K. Efficacy of metformin in the treatment of NIDDM. Meta-analysis. Diabetes Care. 1999;22:33-7.
-
(1999)
Diabetes Care
, vol.22
, pp. 33-37
-
-
Johansen, K.1
-
6
-
-
0042629783
-
What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes
-
Shaughnessy AF, Slawson DC. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ. 2003;327:266-9.
-
(2003)
BMJ
, vol.327
, pp. 266-269
-
-
Shaughnessy, A.F.1
Slawson, D.C.2
-
7
-
-
0029914622
-
Assessing the quality of reports of randomised clinical trials: Is blinding necessary?
-
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
-
(1996)
Control Clin Trials
, vol.17
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
Jenkinson, C.4
Reynolds, J.M.5
Gavaghan, D.J.6
-
8
-
-
85047692188
-
Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
-
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12.
-
(1995)
JAMA
, vol.273
, pp. 408-412
-
-
Schulz, K.F.1
Chalmers, I.2
Hayes, R.J.3
Altman, D.G.4
-
10
-
-
0034791788
-
Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients
-
Charpentier G, Fleury F, Kabir M, Vaur L, Halimi S. Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. Diabet Med. 2001;18:828-34.
-
(2001)
Diabet Med
, vol.18
, pp. 828-834
-
-
Charpentier, G.1
Fleury, F.2
Kabir, M.3
Vaur, L.4
Halimi, S.5
-
11
-
-
0037363570
-
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea
-
Goldstein BJ, Pans M, Rubin CJ. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea. Clin Ther. 2003;25:890-903.
-
(2003)
Clin Ther
, vol.25
, pp. 890-903
-
-
Goldstein, B.J.1
Pans, M.2
Rubin, C.J.3
-
12
-
-
0029099086
-
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
-
The Multicenter Metformin Study Group
-
DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med. 1995;333:541-9.
-
(1995)
N Engl J Med
, vol.333
, pp. 541-549
-
-
Defronzo, R.A.1
Goodman, A.M.2
-
13
-
-
0027935577
-
Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study
-
Hermann LF, Schersten B, Bitzen PO, Kjellstrom T, Lindgärde F, Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care. 1994;17:1100-9.
-
(1994)
Diabetes Care
, vol.17
, pp. 1100-1109
-
-
Hermann, L.F.1
Schersten, B.2
Bitzen, P.O.3
Kjellstrom, T.4
Lindgärde, F.5
Melander, A.6
-
14
-
-
0031460261
-
Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: The Essen-II Study
-
Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study. Am J Med. 1997;103:483-90.
-
(1997)
Am J Med
, vol.103
, pp. 483-490
-
-
Hoffmann, J.1
Spengler, M.2
-
15
-
-
0035374524
-
The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes
-
Chiasson JL Nadtich L, for the Miglitol Canadian University Investigator Group. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. Diabetes Care. 2001;24:989-94.
-
(2001)
Diabetes Care
, vol.24
, pp. 989-994
-
-
Chiasson, J.L.1
Nadtich, L.2
-
16
-
-
0037683740
-
Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes
-
Pavo I, Jermendy G, Varkonyi TT, Kerenyi Z, Gyimesi A, Shoustov S, et al. Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. J Clin Endocrinol Metab. 2003;88:1637-45.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 1637-1645
-
-
Pavo, I.1
Jermendy, G.2
Varkonyi, T.T.3
Kerenyi, Z.4
Gyimesi, A.5
Shoustov, S.6
-
17
-
-
0035167387
-
Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension
-
Uehara MH. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001;3:319-25.
-
(2001)
Diabetes Obes Metab
, vol.3
, pp. 319-325
-
-
Uehara, M.H.1
-
18
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
Turner RC, Holman RR, Stratton IM, Cull CA, Matthews DR, Manley SE, et al, for the UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-65.
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
Turner, R.C.1
Holman, R.R.2
Stratton, I.M.3
Cull, C.A.4
Matthews, D.R.5
Manley, S.E.6
-
19
-
-
0024809869
-
Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients
-
Collier A, Watson HH, Patrick AW, Ludlam CA, Clarke BF. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabete Metab. 1989;15:420-25.
-
(1989)
Diabete Metab
, vol.15
, pp. 420-425
-
-
Collier, A.1
Watson, H.H.2
Patrick, A.W.3
Ludlam, C.A.4
Clarke, B.F.5
-
20
-
-
0025903612
-
Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD
-
Noury J, Nandeuil A. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. Diabete Metab. 1991;17(1 Pt 2):209-12.
-
(1991)
Diabete Metab
, vol.17
, Issue.1 PART 2
, pp. 209-212
-
-
Noury, J.1
Nandeuil, A.2
-
21
-
-
0032995666
-
Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes
-
Tessier D, Maheux P, Khalil A, Fulop T. Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes. Metabolism. 1999;48:897-903.
-
(1999)
Metabolism
, vol.48
, pp. 897-903
-
-
Tessier, D.1
Maheux, P.2
Khalil, A.3
Fulop, T.4
-
22
-
-
0028605970
-
One year comparative trial of metformin and glipizide in type 2 diabetes mellitus
-
Campbell IW, Menzis DG, Chalmers J, McBain AM, Brown IRF. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. Diabete Metab. 1994;20:394-400.
-
(1994)
Diabete Metab
, vol.20
, pp. 394-400
-
-
Campbell, I.W.1
Menzis, D.G.2
Chalmers, J.3
McBain, A.M.4
Brown, I.R.F.5
-
23
-
-
0034464263
-
The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus
-
Amador-Licona N, Guizar-Mendoza J, Vargas E, Sanchez-Camargo G, Zamora-Mata L. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus. Arch Med Res. 2000;31:571-5.
-
(2000)
Arch Med Res
, vol.31
, pp. 571-575
-
-
Amador-Licona, N.1
Guizar-Mendoza, J.2
Vargas, E.3
Sanchez-Camargo, G.4
Zamora-Mata, L.5
-
24
-
-
0031545128
-
Normoglucemia en diabetes mellitus no dependiente de insulina de reciente diagnóstico. Tratamiento no farmacológico vs. tratamiento farmacológico
-
Támez Pérez HE, Gómez de Ossio MD, Ibarra Martínez IB. Normoglucemia en diabetes mellitus no dependiente de insulina de reciente diagnóstico. Tratamiento no farmacológico vs. tratamiento farmacológico. Med Int Mex. 1997;13:272-5.
-
(1997)
Med Int Mex
, vol.13
, pp. 272-275
-
-
Támez Pérez, H.E.1
Gómez De Ossio, M.D.2
Ibarra Martínez, I.B.3
-
25
-
-
27144536879
-
A randomized trial tolbutamide and metformin for persistent severe hyperglycaemia in non insulin dependent diabetes mellitus (NIDDM)
-
Dalzell GW, Hadden DR, Atkinson AB, Kennedy L, Weavwe JA. A randomized trial tolbutamide and metformin for persistent severe hyperglycaemia in non insulin dependent diabetes mellitus (NIDDM). Irish J Med Sci. 1986;155:341-2.
-
(1986)
Irish J Med Sci
, vol.155
, pp. 341-342
-
-
Dalzell, G.W.1
Hadden, D.R.2
Atkinson, A.B.3
Kennedy, L.4
Weavwe, J.A.5
-
26
-
-
3543004668
-
Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin
-
Damsbo P, Hermann LS, Vaag A, Hother-Nielsen O, Beck-Nielsen H. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin. Diabetes Care. 1998;21:1489-94.
-
(1998)
Diabetes Care
, vol.21
, pp. 1489-1494
-
-
Damsbo, P.1
Hermann, L.S.2
Vaag, A.3
Hother-Nielsen, O.4
Beck-Nielsen, H.5
-
27
-
-
0037346965
-
Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients
-
Del Prato S, Erkelens DW, Leutenegger M. Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. Acta Diabetol. 2003;40:20-7.
-
(2003)
Acta Diabetol
, vol.40
, pp. 20-27
-
-
Del Prato, S.1
Erkelens, D.W.2
Leutenegger, M.3
-
28
-
-
0025763252
-
Double-blind evaluation of efficacy and tolerability of metformin in NIDDM
-
Dornan TL, Heller SR, Peck GM, Tattersall RB. Double-blind evaluation of efficacy and tolerability of metformin in NIDDM. Diabetes Care. 1991;14:342-4.
-
(1991)
Diabetes Care
, vol.14
, pp. 342-344
-
-
Dornan, T.L.1
Heller, S.R.2
Peck, G.M.3
Tattersall, R.B.4
-
29
-
-
0030022720
-
The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes
-
Grant PJ. The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes. Diabetes Care. 1996;19:64-6.
-
(1996)
Diabetes Care
, vol.19
, pp. 64-66
-
-
Grant, P.J.1
-
30
-
-
0036895990
-
Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes
-
Hallsten K, Virtanen KA, Lonnqvist F, Sipila H, Oksanen A, Viljanen T, et al. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes. 2002;51:3479-85.
-
(2002)
Diabetes
, vol.51
, pp. 3479-3485
-
-
Hallsten, K.1
Virtanen, K.A.2
Lonnqvist, F.3
Sipila, H.4
Oksanen, A.5
Viljanen, T.6
-
31
-
-
0033754777
-
Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes
-
Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care. 2000;23:1660-5.
-
(2000)
Diabetes Care
, vol.23
, pp. 1660-1665
-
-
Horton, E.S.1
Clinkingbeard, C.2
Gatlin, M.3
Foley, J.4
Mallows, S.5
Shen, S.6
-
32
-
-
0031614038
-
Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
-
Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res. 1998;6:47-53.
-
(1998)
Obes Res
, vol.6
, pp. 47-53
-
-
Lee, A.1
Morley, J.E.2
-
33
-
-
0035312620
-
Improved endothelial function with metformin in type 2 diabetes mellitus
-
Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2001;37:1344-50.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 1344-1350
-
-
Mather, K.J.1
Verma, S.2
Anderson, T.J.3
-
34
-
-
0025893874
-
Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes
-
Teupe B, Bergis K. Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes. Diabetes Metab. 1991;17:213-7.
-
(1991)
Diabetes Metab
, vol.17
, pp. 213-217
-
-
Teupe, B.1
Bergis, K.2
-
35
-
-
0345434811
-
Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes
-
Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, et al. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:119-24.
-
(1999)
Diabetes Care
, vol.22
, pp. 119-124
-
-
Moses, R.1
Slobodniuk, R.2
Boyages, S.3
Colagiuri, S.4
Kidson, W.5
Carter, J.6
-
36
-
-
0032568257
-
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
-
Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998;338:867-72.
-
(1998)
N Engl J Med
, vol.338
, pp. 867-872
-
-
Inzucchi, S.E.1
Maggs, D.G.2
Spollett, G.R.3
Page, S.L.4
Rife, F.S.5
Walton, V.6
-
37
-
-
0029905092
-
Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas
-
Fanghanel G, Sánchez-Reyes L, Trujillo C, Sotres D, Espinosa-Campos J. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas. Diabetes Care. 1996;19:1185-9.
-
(1996)
Diabetes Care
, vol.19
, pp. 1185-1189
-
-
Fanghanel, G.1
Sánchez-Reyes, L.2
Trujillo, C.3
Sotres, D.4
Espinosa-Campos, J.5
-
38
-
-
0028659004
-
Operating characteristics of a rank correlation test for publication bias
-
Begg CB, Mazundar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
-
(1994)
Biometrics
, vol.50
, pp. 1088-1101
-
-
Begg, C.B.1
Mazundar, M.2
-
39
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Davey Smith, G.2
Schneider, M.3
Minder, C.4
-
41
-
-
0041589516
-
Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: A randomized double-blind, comparative study
-
Tosi F, Muggeo M, Brun E, et al. Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized double-blind, comparative study. Metabolism. 2003;52:862-7.
-
(2003)
Metabolism
, vol.52
, pp. 862-867
-
-
Tosi, F.1
Muggeo, M.2
Brun, E.3
-
42
-
-
0034678773
-
Combinig insulin and oral agents
-
Buse J. Combinig insulin and oral agents. Am J Med. 2000;108 Suppl 6A:23-32.
-
(2000)
Am J Med
, vol.108
, Issue.SUPPL. 6A
, pp. 23-32
-
-
Buse, J.1
-
43
-
-
18144447850
-
Antiatherogenic properties of metformin: The experimental evidence
-
Mamputu JC, Wiernsperger NF, Renier G. Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab. 2003;29(4 Pt 2):6S71-6.
-
(2003)
Diabetes Metab
, vol.29
, Issue.4 PART 2
-
-
Mamputu, J.C.1
Wiernsperger, N.F.2
Renier, G.3
-
44
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
-
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
|